Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Aug 12, 2024

30870_dirs_2024-08-12_d7e3e32d-0209-495e-935c-a625c0c017d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-08-12

Reporting Person: PARSHALL B LYNNE (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-12 Common Stock M 5000 $21.61 Acquired 25600 Direct
2024-08-12 Common Stock S 5000 $55.20 Disposed 20600 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-12 Non-Qualified Stock Option (Right to Buy) $21.61 M 5000 Disposed 2030-05-13 Common Stock (5000) Direct

Footnotes

F1: Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant.